Janux Therapeutics JANX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Janux Therapeutics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Janux Therapeutics's total equity?
- Janux Therapeutics (JANX) reported total equity of $941.54M in Q1 2026.
- How has Janux Therapeutics's total equity changed year-over-year?
- Janux Therapeutics's total equity decreased by 7.0% year-over-year, from $1.01B to $941.54M.
- What is the long-term trend for Janux Therapeutics's total equity?
- Over 5 years (2020 to 2025), Janux Therapeutics's total equity has grown at a 130.7% compound annual growth rate (CAGR), from -$14.64M to $956.82M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.